胆汁酸封存减弱了脱硫纤维素诱导的肝损伤
Songfan Yang1, Lingxi Zhou2, Jie Dong1
1School of Life Sciences and Health Engineering, Department of Gastroenterology, Affiliated Hospital of Jiangnan University, Jiangnan University, Wuxi 214122, China.
Microorganisms
|January 28, 2026
概括
减少硫酸盐的细菌Desulfovibrio (DSV) 通过改变胆酸 (BA) 代谢和肠道微生物群的变化,导致肝损伤. 用胆固醇胺调节BA可能为DSV相关的肝病提供治疗效益.
科学领域:
- 微生物学 微生物学
- 胃肠病学 胃肠病学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 脱硫纤维菌 (DSV) 是产生硫化 (H2S) 的肠道细菌,通过胆酸 (BA) 代谢影响宿主健康.
- DSV过度生长与扩大的BA池和肝损伤有关,但其在肝脏病理生理学中的直接因果作用需要进一步定义.
研究的目的:
- 通过异常的胆酸代谢和肠道微生物重塑来调查DSV在肝损伤中的因果作用.
- 探索调节DSV相关肝脏疾病中的胆酸动态的治疗潜力.
主要方法:
- 使用小鼠模型与胆酸 (CA) 补充剂和胆固醇胺 (BA 序列剂) 干预.
- 分析了肝损伤,炎症和组织学变化,以及肝脏BA合成基因表达 (Cyp7a1,Cyp8b1).
- 采用16S rRNA基因测序来评估肠道微生物群的组成和变化.
主要成果:
- 补充CA诱导肝损伤;DSV没有加剧过量的CA造成的损伤.
- 胆固醇胺减弱了DSV引起的肝炎和组织学变化,与肠道BA池增加相关.
- CA,DSV和胆固醇胺显著改变了肠道微生物群;胆固醇胺减轻了与DSV相关的微生物转移.
结论:
- DSV驱动的肝损伤涉及异常的BA代谢和肠道微生物的改变.
- 胆酸动态在塑造肠道微生物群体中起着不可或缺的作用.
- 胆汁酸的调节为DSV相关的肝病提供了潜在的治疗策略.
相关概念视频
Transcription Attenuation in Prokaryotes
18.4K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.4K
Bile
4.1K
Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
Bile is released when dietary fats enter...
4.1K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
270
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
270
Hepatic Portal System
5.8K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.8K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
227
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
227
Amino acids
105.2K
Amino acids are the monomers that comprise proteins. Each amino acid has the same fundamental structure, which consists of a central carbon atom, or the alpha (α) carbon, bonded to an amino group (NH2), a carboxyl group (COOH), and to a hydrogen atom. Every amino acid also has another atom or group of atoms bonded to the central atom known as the R group. There are 20 common amino acids present in proteins, each with a different R group. Variation in the amino acid sequence is responsible for...
105.2K


